Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Pediatric Pulmonology
|
December 19, 2013
Survival of an infant with homozygous surfactant protein C (SFTPC) mutation
Zeynep Arıkan-Ayyıldız, Sule Caglayan-Sozmen, Sakine Isık, et al.
The Laryngoscope
|
March 29, 2019
Demonstrating the benefits of a multidisciplinary aerodigestive program
Amanda G Ruiz, Jay M Bhatt, Emily M DeBoer, et al.
Physiological Measurement
|
March 23, 2018
Evaluation of surrogate measures of pulmonary function derived from electrical impedance tomography data in children with cystic fibrosis
Peter A Muller, Jennifer L Mueller, Michelle Mellenthin, et al.
Pediatric Pulmonology
|
May 28, 2011
Frequency, treatment, and functional outcome in children with hypersensitivity pneumonitis
Frederik Buchvald, Bodil Laub Petersen, Karen Damgaard, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 16, 2017
Unsedated In-office Transgastrostomy Esophagoscopy to Monitor Therapy in Pediatric Esophageal Disease
Caroline H T Hall, Nathalie Nguyen, Glenn T Furuta, et al.
Pediatric Pulmonology
|
June 27, 2013
Diffuse lung disease in children: summary of a scientific conference
Aaron Hamvas, Robin Deterding, William E Balch, et al.
Pediatric Pulmonology
|
January 30, 2024
Estimating the effect of nintedanib on forced vital capacity in children and adolescents with fibrosing interstitial lung disease using a Bayesian dynamic borrowing approach
Toby M Maher, Kevin K Brown, Steven Cunningham, et al.
Pediatric Pulmonology
|
June 22, 2026
Continued Nintedanib Treatment in Children and Adolescents With Fibrosing ILDs: Data From InPedILD-ON
Robin Deterding, Lisa R Young, Emily M DeBoer, et al.
Pediatric Pulmonology
|
February 11, 2005
Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis
Robin Deterding, George Retsch-Bogart, Laura Milgram, et al.
The European Respiratory Journal
|
August 30, 2022
Nintedanib in children and adolescents with fibrosing interstitial lung diseases
Robin Deterding, Lisa R Young, Emily M DeBoer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Pediatric Pulmonology
|
December 19, 2013
Survival of an infant with homozygous surfactant protein C (SFTPC) mutation
Zeynep Arıkan-Ayyıldız, Sule Caglayan-Sozmen, Sakine Isık, et al.
The Laryngoscope
|
March 29, 2019
Demonstrating the benefits of a multidisciplinary aerodigestive program
Amanda G Ruiz, Jay M Bhatt, Emily M DeBoer, et al.
Physiological Measurement
|
March 23, 2018
Evaluation of surrogate measures of pulmonary function derived from electrical impedance tomography data in children with cystic fibrosis
Peter A Muller, Jennifer L Mueller, Michelle Mellenthin, et al.
Pediatric Pulmonology
|
May 28, 2011
Frequency, treatment, and functional outcome in children with hypersensitivity pneumonitis
Frederik Buchvald, Bodil Laub Petersen, Karen Damgaard, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
May 16, 2017
Unsedated In-office Transgastrostomy Esophagoscopy to Monitor Therapy in Pediatric Esophageal Disease
Caroline H T Hall, Nathalie Nguyen, Glenn T Furuta, et al.
Pediatric Pulmonology
|
June 27, 2013
Diffuse lung disease in children: summary of a scientific conference
Aaron Hamvas, Robin Deterding, William E Balch, et al.
Pediatric Pulmonology
|
January 30, 2024
Estimating the effect of nintedanib on forced vital capacity in children and adolescents with fibrosing interstitial lung disease using a Bayesian dynamic borrowing approach
Toby M Maher, Kevin K Brown, Steven Cunningham, et al.
Pediatric Pulmonology
|
June 22, 2026
Continued Nintedanib Treatment in Children and Adolescents With Fibrosing ILDs: Data From InPedILD-ON
Robin Deterding, Lisa R Young, Emily M DeBoer, et al.
Pediatric Pulmonology
|
February 11, 2005
Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis
Robin Deterding, George Retsch-Bogart, Laura Milgram, et al.
The European Respiratory Journal
|
August 30, 2022
Nintedanib in children and adolescents with fibrosing interstitial lung diseases
Robin Deterding, Lisa R Young, Emily M DeBoer, et al.
Page
of 3